Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;45(12):5985-97.
doi: 10.1016/j.ejmech.2010.09.065. Epub 2010 Oct 7.

4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation

Affiliations

4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation

Snehlata Yadav et al. Eur J Med Chem. 2010 Dec.

Abstract

A series of 4-[1-(substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzene sulphonic acids (1-20) was synthesized and evaluated, in vitro, for their antimicrobial activity and the results indicated that compounds 4-[1-(4-Nitrobenzoyl)-1H-benzoimidazol-2-yl]-benzenesulfonic acid (9) and 4-(1-octadec-9-enoyl-1H-benzoimidazol-2-yl)-benzenesulfonic acid (18) were found to be the most active ones. QSAR investigations indicated that the multi-target QSAR model was effective in describing the antimicrobial activity over the one-target QSAR models. Further the mt-QSAR model indicated the importance of the topological parameter, Balaban index (J) followed by the electronic parameter, LUMO and topological parameter, valence second order molecular connectivity index (2χv) in describing the antimicrobial activity of synthesized compounds (1-20).

PubMed Disclaimer

Figures

None
Graphical abstract
Scheme 1
Scheme 1
Scheme for the synthesis of 4-[1-(substituted aryl/alkyl)-benzoimidazol-2-yl]-benzenesulfonic acids.
Fig. 1
Fig. 1
Plot of predicted pMICsa against the experimental pMICsa for the MLR model developed by Eq. (3).
Fig. 2
Fig. 2
Plot of residual pMICsa against the experimental pMICsa by Eq. (3).
Fig. 3
Fig. 3
Plot of predicted pMICam against the experimental pMICam values for the MLR model developed by Eq. (13).
Fig. 4
Fig. 4
Plot of predicted pMICam values against the experimental pMICam values for the MLR model developed by Eq. (13).
None

Similar articles

Cited by

References

    1. Saleh M., Abbott S., Lauzon V.C., Penney C., Zacharie B. Bioorg. Med. Chem. Lett. 2010;20:945–949. - PubMed
    1. Miller J.F., Turner E.M., Gudmundsson K.S., Jenkinson S., Spaltenstein A., Thomson M., Wheelan P. Bioorg. Med. Chem. Lett. 2010;20:2125–2128. - PubMed
    1. Tonelli M., Simone M., Tasso B., Novelli F., Boido V., Sparatore F., Paglietti G., Pricl S., Giliberti G., Blois S., Ibba C., Sanna G., Loddo R., Colla P.L. Bioorg. Med. Chem. 2010;18:2937–2953. - PubMed
    1. Luo X., Zhang Z., Yang Y., Xue F., Xiu N., She Y. Front. Chem. Eng. China. 2009;3(3):305–309.
    1. Pilyugin V.S., Kuznetsova S.L., Sapozhnikov Y.E., Chikisheva G.E., Kiseleva G.V., Vorob’eva T.P., Klimakova E.V., Sapozhnikova N.A., Davletov R.D., Galeeva Z.B. Russ. J. Gen. Chem. 2008;78(3):446–450.

Publication types

MeSH terms

LinkOut - more resources